Mycobacterium tuberculosis drug resistance, Ghana [7]

Emerging Infectious Diseases

Volumn 12, Issue 7, 2006, Pages 1170-1172

  Owusu Dabo, Ellis ^a   Adjei, Ohene ^a   Meyer, Christian G ^b   Horstmann, Rolf D ^b   Enimil, Anthony ^c   Kruppa, Thomas F ^d   Bonsu, Frank ^e   Browne, Edmund N L ^a   Chinbuah, Margaret Amanua ^f   Osei, Ivy ^f   Gyapong, John ^f   Berberich, Christof ^a   Kubica, Tanja ^g   Niemann, Stefan ^g   Ruesch Gerdes, Sabine ^g  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^d KUMASI CENTRE FOR COLLABORATIVE RESEARCH IN TROPICAL MEDICINE   (Ghana)

^e National Tuberculosis Programme   (Ghana)

^f MINISTRY OF HEALTH   (Ghana)

^g National Reference Center for Mycobacteria   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; DIRECTLY OBSERVED THERAPY; DRUG RESISTANCE; GHANA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; LETTER; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PUBLIC HEALTH SERVICE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 33745962814     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1207.051028     Document Type: Letter

References (5)

1. National Tuberculosis Control Programme. Annual report 2003. Accra (Ghana): The Programme; 2003.
2. van der Werf TS, Groothuis DG, van Klingeren B. High initial drug resistance in pulmonary tuberculosis in Ghana. Tubercle. 1989;70:249-55.
3. Lawn SD, Frimpong EH, Al-Ghusein H, Acheampong JW, Uttley AH, Butcher PD, et al. Pulmonary tuberculosis in Kumasi, Ghana: presentation, drug resistance, molecular epidemiology and outcome of treatment. West Afr J Med. 2001;20:92-7.
4. Farmer P, Bayona J, Becerra M, Furin J, Henry C, Hiatt H, et al. The dilemma of MDR-TB in the global era. Int J Tuberc Lung Dis. 1998;2:869-76.
5. World Health Organization. Anti-tuberculosis drug resistance in the world. Third global report. WHO/HTM/TB/2004.323. Geneva: The Organization; 2004.